WithdrawnPhase 4MS (type not specified)NCT00988988

What it found

Stopped early

The trial ended early for another reason (see below).

Reason given: Not approved by IRB

What was tested

Treatment tested

  • AGEE cream
  • 1% Steroid Cream

Placebo or sham

  • topical placebo cream with no active ingredients

What it measured

Main measures

  • Histamine response after ethyl-α-guanida-methyl ethanoate (AGEE) and subcutaneous injection of glatiramer acetate

    Three weeks

Who could take part

MS (type not specified) · 19 to 65

Inclusion Criteria: * Able to give informed consent * Between ages 19-65 * Laboratory supported diagnosis of multiple sclerosis * Currently treated with injectable GA, experiencing wheal and flare after injection Exclusion Criteria: * Unable to give informed consent * Treated with any other therapy for Multiple Sclerosis

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Participants with multiple sclerosis that are currently treated with glatiramer acetate (GA, Copaxone®) injections and have redness, pain, swelling, itching or a lump at the injection site will be recruited to examine histamine response of three topical treatments to reduce these symptoms.

Loading reviews and guidelines…

Related trials

History

    1. Started

      Feb 2010

    2. Main results due

      Aug 2012

    3. Finished

      Aug 2012

    Assembled by software from public sources and not checked by people. Each record links to its source. Report an error